This symposium will present the clinical information and research data affecting men with mCRPC (metastatic castrate-resistant prostate cancer) and discuss novel therapeutic categories with an overall goal of educating the audience on new pathways to improve patient outcomes. Through interactive real case vignettes, this educational activity will explore current clinical issues, best practices, and promising future directions in the treatment of men with mCRPC.